Core Viewpoint - 康健国际医疗 collaborates with Pfizer Hong Kong to promote respiratory health education and provide 20-valent pneumococcal conjugate vaccines to underprivileged communities in Hong Kong [1][2] Group 1: Collaboration and Initiatives - 康健国际医疗, through its charity fund, donates a batch of 20-valent pneumococcal conjugate vaccines to the Tung Wah Group of Hospitals for community health protection [1] - The partnership aims to shift public health perception from "treatment-based" to "prevention-based" [1][2] - The extensive network of medical centers across Hong Kong will facilitate public access to the vaccines [1] Group 2: Public Health Impact - Pneumonia is the second leading cause of death in Hong Kong, with over 11,000 deaths in 2024, making it more lethal than heart disease and cerebrovascular diseases [4] - Pneumococcal infections pose a significant public health threat, particularly to the elderly and vulnerable populations [3][4] - Vaccination is highlighted as the most effective method to prevent pneumococcal diseases, significantly reducing the risk of invasive infections and severe outcomes [4] Group 3: Community Engagement - The Tung Wah Group of Hospitals will play a crucial role in distributing the donated vaccines and identifying suitable beneficiaries for vaccination [1][2] - The collaboration emphasizes the importance of community health investment and aims to alleviate the disease burden on vulnerable groups [3]
康健国际医疗联合辉瑞香港开展呼吸道健康教育 捐赠肺炎疫苗惠及弱势社群